- Home
- SBFM vs MHH Comparison
SBFM vs MHH Comparison
Compare SBFM & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MHH
- Stock Information
- Founded
- SBFM 2006
- MHH 1986
- Country
- SBFM United States
- MHH United States
- Employees
- SBFM N/A
- MHH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- SBFM Health Care
- MHH Consumer Discretionary
- Exchange
- SBFM Nasdaq
- MHH Nasdaq
- Market Cap
- SBFM 4.9M
- MHH N/A
- IPO Year
- SBFM N/A
- MHH N/A
- Fundamental
- Price
- SBFM $1.55
- MHH $7.84
- Analyst Decision
- SBFM Strong Buy
- MHH
- Analyst Count
- SBFM 1
- MHH 0
- Target Price
- SBFM $15.00
- MHH N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- MHH 15.5K
- Earning Date
- SBFM 05-19-2025
- MHH 05-07-2025
- Dividend Yield
- SBFM N/A
- MHH N/A
- EPS Growth
- SBFM N/A
- MHH N/A
- EPS
- SBFM N/A
- MHH 0.28
- Revenue
- SBFM $34,874,283.00
- MHH $198,943,000.00
- Revenue This Year
- SBFM $192.48
- MHH $2.17
- Revenue Next Year
- SBFM N/A
- MHH $4.43
- P/E Ratio
- SBFM N/A
- MHH $27.68
- Revenue Growth
- SBFM 44.75
- MHH N/A
- 52 Week Low
- SBFM $1.17
- MHH $7.15
- 52 Week High
- SBFM $33.60
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- SBFM 44.81
- MHH 39.45
- Support Level
- SBFM $1.17
- MHH $7.26
- Resistance Level
- SBFM $1.59
- MHH $8.45
- Average True Range (ATR)
- SBFM 0.19
- MHH 0.79
- MACD
- SBFM 0.03
- MHH 0.03
- Stochastic Oscillator
- SBFM 52.84
- MHH 30.10
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.